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uation, morphologic classification, and postoperative con-
trols were performed by means of magnetic resonance
angiography (MRA) imaging.
All procedures were performed in an interventional
operating room with a state-of-the-art angiography unit
(Philips Integris V 5000; Philips Medizin Systems,
Hamburg, Germany). CO2 serves as a negative contrast
medium. Although CO2 angiography can be performed
on a standard fluoroscopy unit, the results are consider-
ably improved by special acquisition and postprocessing
software, which is standard for all major types of angiog-
raphy units.
CO2 was administered with a dedicated power injector,
which allows controlled injection of the gas at constant and
reproducible flow rates and volumes. A integrated constant
saline drip avoided intermittent contamination with room
air and air embolism. The gas line to the angiography
catheter and the catheter itself were automatically flushed
before the diagnostic injection, thus avoiding uncontrol-
lable explosive liberation of CO2. Finally, the injection was
electrocardiogram gated, providing a homogeneous arte-
rial contrast in the low-flow diastole. Most of these features
cannot be achieved by means of manual injection devices
such as bags and syringes, which are known to have a high
risk of room air contamination.
The CO2JECT Injector Model is available for DM
65,000 (DM 65,000 is approximately US $32,000). In
addition, the mandatory special CO2 catheter set (CO2
Connect, Medex Medical) must be purchased for DM
130. The costs are comparable with those of conventional
catheter material. 
On the basis of collected morphometric data, an AAA
classification with possible graft configuration was
described earlier.4 All the cases presented were classified
on the basis of this classification system.
CASE 1
A 47-year-old man with an asymptomatic infrarenal AAA
(type IIb) with a maximum diameter of 5 cm (Fig 1)4,6 had
Compared with iodinated contrast media, carbon
dioxide (CO2) angiography has some remarkable advan-
tages: the gas is not toxic, it has no allergic potential, and
it is not ionic. In addition, it is inexpensive and easily avail-
able. In patients with abdominal aortic aneurysm (AAA)
and preexisting renal failure who are candidates for
endovascular surgery, which is associated with a consider-
able amount of contrast material, angiography may be per-
formed with CO2 as a contrast agent to prevent major
acute renal dysfunction and dialysis.1-3 When allergic reac-
tions to conventional contrast media are known and pre-
existing hyperthyroidism is also a factor, CO2 might also
be used as a contrast material, instead of intensive medical
pretreatment.3
We report on three high-risk patients (ASA III) with
infrarenal AAAs who required therapy to prevent rupture.
In all cases, an AAA morphology suitable for endovascular
exclusion was confirmed by means of a preoperative eval-
uation.4 Although CO2 angiography is proven to be safe
in combination with vascular interventions, to our knowl-
edge there are no data available about CO2-assisted aortic
stent graft placement.5
METHODS
Intraoperative CO2 angiography was performed with
an automatic gas administration set (CO2JECT, Medex
Medical, Klein-Winternheim, Germany) to ensure repro-
ducible gas volume flow in all cases. All CO2-assisted
angiographic procedures were done with an 80 mL/s gas
flow rate and 100 mL gas volume. Preoperative AAA eval-
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Allergic reactions to contrast media, preexisting renal dysfunction, and hyperthyroidism are relative contraindications for
angiography with conventional contrast medium. Carbon dioxide (CO2) angiography is an alternative method in high-
risk patients because CO2 is nontoxic, without allergic potential, and not iodic. CO2-related complications are extremely
rare. Because renal insufficiency often occurs in vascular patients, this method will become increasingly important for
endovascular surgery. We report on three consecutive patients with asymptomatic infrarenal aortic aneurysm and con-
comitant renal dysfunction or allergic reactions to standard contrast media. Aortic stent grafts were deployed under CO2
angiographic control without complications or worsening of renal function. (J Vasc Surg 2001;33:646-9.)
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polycystic kidneys (autosomal-dominant disease) and resulting
renal dysfunction, although the disease was stable (Fig 1). His
AAA was first diagnosed during routine abdominal ultrasonog-
raphy for his huge polycystic kidneys. After preoperative mor-
phologic evaluation for transluminal endovascular placed graft
(TPEG), the patient underwent general anesthesia, and the
TPEG was placed and controlled by means of CO2 angiography
(Excluder Bifurcation stent; W.L. Gore, Flagstaff, Ariz; Fig 2).
The preoperative creatinine level was compensated at 2.5
mg/dL and remained unchanged during and after the proce-
dure. There were no notable adverse effects. The procedure had
no complications. No primary leakage could be observed in the
CO2-assisted angiography after correct placement. A correctly
placed bifurcation stent starting exactly below the renal arteries
was shown by means of postoperative gadolinium-enhanced
MRA (Fig 3).
CASE 2
An asymptomatic infrarenal AAA with a maximum diameter
of 7.5 cm, starting 2 cm distal to the renal arteries, was revealed
by means of routine abdominal ultrasonography in a 69-year-old
man.4,6 The common iliac arteries reached normal sizes 3 cm
proximal to the iliac bifurcation on both sides. The patient had
had a severe allergic reaction to conventional contrast medium
during previous peripheral angiography and a coexisting renal
dysfunction in a compensated status (creatinine level, 1.4 mg/dL;
urea level, 43 mg/dL). Therefore, preoperative evaluation for a
TPEG was performed by means of MRA. The infrarenal AAA was
classified as type IIb, according to the Allenberg classification,
with an adequate proximal neck and distal anchoring in the com-
mon iliacs (Fig 4).4,6 Other risk factors were diabetes mellitus
(type IIb), hypertension, and obesity.
After preoperative evaluation for TPEG, the patient under-
went general anesthesia, and the TPEG (Vanguard Bifurcation
stent; (Boston Scientific Corp, Oakland, NJ) was placed and con-
trolled by means of CO2 angiography. Preoperative creatinine and
urea levels remained unchanged during and after the procedure.
There were no notable adverse effects. The procedure was per-
formed without any notable complications. TPEG could be accu-
rately placed just below the renal arteries down to the iliac
bifurcation. No primary leakage could be visualized by means of
the CO2-assisted completion angiography, which was confirmed
by means of MRA after 2 days.
CASE 3
A 75-year-old man had an asymptomatic infrarenal AAA
(type IIa)4,6 with a maximum diameter of 6 cm. The proximal
aortic neck was shown to be suitable for endovascular stent graft
placement (2.5 cm below renal arteries) by means of preoperative
magnetic resonance imaging (MRI). The AAA ended at the level
of aortic bifurcation, and the renal arteries showed no stenosis by
Fig 1. MRI showing infrarenal asymptomatic AAA and polycys-
tic kidneys on both sides.
Fig 2. Intraoperative CO2 angiography with transvascularly
placed aortic stent graft (bifurcation stent).
Fig 3. Postoperative MRI showing a correct transvascularly
placed aortic stent (bifurcation stent).
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means of the MRI. The known risk factors were hypertension and
type 1 diabetes mellitus. Diabetes mellitus was first diagnosed in
the patient 5 years earlier, and he had diabetes-related renal dys-
function and stable disease. The preoperative creatinine level was
stable at 3.0 mg/dL, and the urea level was 82 mg/dL. The
TPEG (Vanguard bifurcation stent; Boston Scientific Corp) was
placed without changing the renal function, and the preoperative
creatinine level remained unchanged during and after the proce-
dure.
DISCUSSION
There is a high risk of renal failure after angiography
with iodinated contrast medium, especially in patients
with preexisting renal dysfunction. However, there is a sig-
nificantly higher comorbidity for renal dysfunction in vas-
cular patients because of the higher number who have
diabetes mellitus and renovascular arteriosclerosis.
Hernandez-Richter et al2 demonstrated that diabetes mel-
litus is an established risk factor (8.7%) in vascular and
AAA patients.
Martin-Paredero et al1 described acute renal dysfunc-
tion (ARD) in 11.3% of patients who underwent abdomi-
nal and runoff angiography (n = 400). Of the group of
patients with normal renal function before the procedure,
8.2% had ARD. However, only 0.8% of patients required
dialysis after angiography with iodinated contrast material.
Patients with earlier abnormal renal function had a 41.7%
incidence of ARD, and 8.3% of them required dialysis as a
result of angiography. For patients with known severe
allergic reactions, severe renal dysfunction, or both, the
last two statements have to be taken into consideration
when deciding on the interventional treatment of AAA,
because a high amount of contrast material is required for
TPEG placement.
Allergic reactions may occur in as many as 10% of
patients after angiography with iodine contrast material.
However, severe allergic reactions requiring therapy were
only observed in 2.2% of patients. When allergic reac-
tions to iodinated contrast material is a known factor,
pretreatment with corticosteroids and antihistamine
medication is mandatory so that the risk of severe reac-
tions is minimized.3 Severe allergic reactions in patients
not known to have a predisposition for such reactions are
very rare.
In addition to its allergic potential and capacity for
causing renal function impairment, the application of
contrast material in patients with chronic or acute heart
failure or unknown hyperthyroidism can be critical, so
pretreatment or posttreatment is required. Therefore,
the negative contrast material CO2 can be used as a good
alternative, because it has some remarkable advantages in
selected cases, such as those presented. However, its use
requires a special gas application system for adequate gas
flow and volume control. A special postprocessing soft-
ware for the angiography machines improves the fluo-
roscopy results significantly and is standard in all major
angiography units. One case was published in which a
CO2-related death occurred after aortography after gas
injection by hand.7 In patients with AAA and preexisting
renal failure, it seems reasonable to perform angiography
with CO2 as a contrast agent to prevent major acute
renal dysfunction and dialysis. A combination of CO2
Fig 4. Morphometric AAA definitions and possible graft configurations. Type I, proximal neck > 15 mm and distal cuff > 10 mm (tubu-
lar endograft); type IIA, proximal neck > 15 mm and AAA down to aortic bifurcation (bifurcated endograft); type IIB, proximal neck >
15 mm and aneurysmal involvement of the proximal common iliac arteries (bifurcated endograft); type IIC, proximal neck > 15 mm and
AAA down to the iliac bifurcation (open surgery); type III, proximal neck > 15 mm and distal AAA expansion (open surgery).6
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and conventional contrast material for major angiogra-
phies may reduce the amount of conventional contrast
material required. However, the presented cases were
performed without any additional iodinated contrast
medium.
When the patient has known severe allergic reactions
to conventional contrast media and hyperthyroidism, it is
advisable to use CO2 angiography instead of intensive
medical pretreatment. CO2 digital subtraction angiogra-
phy is already established in the evaluation of renal arter-
ies, the imaging of renal allograft dysfunction, and the
follow-up of renal artery bypass grafts.8-12 CO2 has been
shown to be a safe contrast agent for vascular imaging in
patients with impaired renal function who require defini-
tive vascular imaging or therapy.8
Aortic stent graft placement for infrarenal AAA has
been safe, easy to perform, and without complications. In
particular, there have been no negative effects on preexist-
ing renal insufficiency, as in our cases. In our patients, the
adverse effects described in the literature, such as abdom-
inal pain, nausea, and vomiting, were not noted.13
Reduced contrast is a known disadvantage of CO2
angiography, but this can be improved significantly with
special postprocessing imaging software and continuous
gas flow. Hand application techniques (syringes, bags) can
lead to inhomogeneous, unreproducible gas flow, result-
ing in a reduction in the image quality and bearing the risk
of invisible room air contamination. Therefore, we recom-
mend automatic CO2 application to avoid these problems.
The reduction in image contrast compared with conven-
tional angiography with iodinated contrast material did
not have an influence on accurate stent placement in our
cases.
CONCLUSION
CO2 angiography is a good alternative in vascular
patients with contraindications for ionic iodinated contrast
material (eg, renal insufficiency, allergic reactions, and
hyperthyroidism). Because renal insufficiency often occurs
in vascular patients and the increased number of endovas-
cular procedures, CO2 angiography may play a major role
in the future. Despite the reduced contrast enhancement
compared with iodine contrast mediums, CO2 angiogra-
phy is a safe method for aortic stent graft placement. CO2
should be applied by an automatic gas administration set
to ensure reproducible gas-volume flow.
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